ORMPORAMED PHARMACEUTICALS INC.同业对比
ORAMED PHARMACEUTICALS INC. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ORMP本股 | $168M#8 | 1.0x#2 | 0.8x#5 | 84.2x#5 | — | 573.1%#1 | -754.4%#4 | 0.0%#2 | -4.4%#1 | — | 70.5%#3 | — |
| INO | $181M#1 | — | 41.4x#12 | 2769.2x#6 | -70.0%#4 | 20.6%#6 | -132871.3%#6 | -1944.6%#13 | -243.9%#4 | — | -25.5%#4 | — |
| TRDA | $178M#2 | — | 0.8x#4 | 7.0x#2 | -87.9%#5 | -319.0%#12 | -621.1%#3 | -61.6%#7 | — | — | — | — |
| UPB | $176M#3 | — | 0.6x#3 | 61.6x#3 | 20.4%#2 | -128.4%#10 | -5618.8%#5 | -52.9%#6 | — | — | -87.6%#7 | — |
| ALXO | $176M#4 | — | 1.3x#6 | — | — | 24.6%#5 | — | -74.7%#9 | -84.4%#3 | — | — | — |
| CNTN | $170M#5 | — | 0.4x#1 | — | — | -194.5%#11 | — | -7.9%#3 | — | — | -27.1%#5 | — |
| SION | $169M#6 | — | 0.6x#2 | — | — | -22.0%#9 | — | -28.3%#4 | — | — | — | — |
| ANTX | $168M#7 | — | 2.2x#8 | — | — | 31.5%#3 | — | -46.3%#5 | — | — | 269.0%#1 | — |
| CURX | $168M#9 | — | 35.1x#11 | — | — | -1068.8%#13 | — | -88.2%#11 | — | — | — | — |
| PEPG | $162M#10 | — | 1.4x#7 | — | — | 0.4%#7 | — | -75.0%#10 | — | — | -49.9%#6 | — |
| MBRX | $158M#11 | 0.6x#1 | 13.6x#9 | — | — | 28.8%#4 | — | 289.6%#1 | — | — | — | — |
| CUE | $154M#12 | — | 66.7x#13 | 5.6x#1 | 195.7%#1 | 34.6%#2 | -96.7%#1 | -1151.6%#12 | — | — | — | — |
| KRSA | $147M#13 | — | 28.9x#10 | 70.9x#4 | 3.7%#3 | -15.4%#8 | -239.8%#2 | -69.4%#8 | -69.1%#2 | — | 139.9%#2 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-03。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议